EVEROLD LONG TERM FOLLOW-UP

Launched by UNIVERSITY HOSPITAL, BREST · Jul 10, 2024

Keywords

ClinConnect Summary

The EVEROLD LONG TERM FOLLOW-UP trial is studying the long-term effects of a previous research study called EVEROLD, which looks at complications and failures in transplant patients. This trial is currently recruiting participants who are between the ages of 65 and 74 and have already completed a follow-up visit for the earlier study. To join, patients need to have agreed to participate in this observational study and consent to the use of their medical data.

If you choose to participate, you can expect to share your health information over a longer period to help researchers understand how transplant outcomes change over time. It's important to note that patients who do not wish to have their medical information used or those who are under legal protection cannot participate in this study. This research aims to improve care for future transplant patients by learning from those who have already gone through the process.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Informed patients participating to the EVEROLD study
• • Patient having completed the EVEROLD M12 follow-up visit
• • Patient agreeing to participate in the observational study
• Exclusion Criteria:
• • Opposition to the use his medical data
• • Patient under legal protection